Literature DB >> 9001426

Radiation-enhanced expression of interferon-inducible genes in the KG1a primitive hematopoietic cell line.

E Clave1, E D Carosella, E Gluckman, G Socié.   

Abstract

X-ray treatment induces a complex molecular response in hematopoietic cells leading to cell death. Using the mRNA differential display technique, we searched for genes whose expression was modified by ionizing radiation (IR) in the human p53-deficient leukemic cell line KG1a. We isolated a partial cDNA corresponding to the interferon (IFN)-inducible 1-8d gene. The expression of both 1-8d and 9-27, another gene from the same IFN-inducible family, was increased 24 and 48 h following irradiation. We did not find enhancement of either IFNgamma mRNA or interferon regulatory factor-1 (IRF-1) mRNA in irradiated KG1a cells, indicating that 1-8d and 9-27 enhancement was not due to an IFN activation. Thus, the induction of IFN-inducible genes by IR may provide a link between radiation-induced and IFN-mediated cell death.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9001426     DOI: 10.1038/sj.leu.2400528

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  3 in total

1.  Functional Implications in Apoptosis by Interferon Inducible Gene Product 1-8D, the Binding Protein to Adenovirus Preterminal Protein.

Authors:  Insil Joung; Peter C Angeletti; Jeffrey A Engler
Journal:  J Microbiol       Date:  2003       Impact factor: 3.422

2.  No role of IFITM3 in brain tumor formation in vivo.

Authors:  Nevenka Dudvarski Stankovic; Nicola Hoppmann; Marcin Teodorczyk; Ella L Kim; Matthias Bros; Alf Giese; Frauke Zipp; Mirko H H Schmidt
Journal:  Oncotarget       Date:  2016-12-27

3.  '1-8 interferon inducible gene family': putative colon carcinoma-associated antigens.

Authors:  B Tirosh; V Daniel-Carmi; L Carmon; A Paz; G Lugassy; E Vadai; A Machlenkin; E Bar-Haim; M-S Do; I S Ahn; M Fridkin; E Tzehoval; L Eisenbach
Journal:  Br J Cancer       Date:  2007-12-11       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.